Why Assessment Comes Before Equipment Selection

Debridement removes devitalised tissue when clinically appropriate. Negative pressure wound therapy (NPWT) has a different role: it applies controlled suction through a wound dressing to manage fluid and support selected wound-care pathways. Purchasing one system does not establish that a wound needs it.

The assessment should explain the intended goal and why the proposed intervention fits this wound. For diabetes-related foot disease, standard care also addresses factors such as offloading, perfusion and infection. NPWT does not replace these measures. IWGDF Wound Healing Guideline, 2023

What Should A Wound Assessment Record Include?

The following discussion checklist helps you review whether the handover is complete. It is not a diagnostic score or an instruction to examine or treat a wound. Clinical findings must be established and interpreted by qualified professionals.

Wound Cause, History And Care Goal

The record should identify the wound location, duration, likely cause, previous treatment and change over time. Pressure, surgery, trauma, diabetes-related foot disease and vascular problems are different contexts; a shared appearance does not establish a shared treatment pathway.

You also need clarity about the care goal. Healing, preparation for closure and symptom management can place different demands on the service. Record the responsible clinician and any unresolved diagnostic questions.

Wound Bed, Dimensions And Surrounding Skin

A useful handover describes the wound rather than relying on labels such as “large” or “clean.” Relevant findings include:

• Documented length, width and depth, with any limits to assessment.
• Tissue present, including viable tissue, slough or eschar.
• Any identified undermining, tunnels or exposed structures.
• Exudate amount and character, wound edges and surrounding skin condition.
• Pain or sensation changes and comparison with earlier assessments.

These are documentation prompts, not directions for probing or removing tissue. The institution determines the assessment method. In diabetes-related foot ulcers, IWGDF specifically includes site, ischaemia, neuropathy, infection, area and depth in its assessment framework. Its scope is the diabetic foot, not every wound category. IWGDF Practical Guidelines, 2023

Perfusion And Factors Affecting Healing

For a lower-limb wound, the record should clarify whether blood supply has been assessed and whether vascular review is outstanding. The visible wound surface cannot settle that question. In diabetes-related foot disease, IWGDF combines clinical findings with appropriate vascular tests; this article does not provide test thresholds for selecting treatment.

The clinical team also considers the wider person, including pressure exposure, mobility, nutritional concerns and relevant illnesses. For pressure injuries, these belong within comprehensive assessment and care planning. WHS Pressure Ulcer Guidelines, 2023

Which Findings Need Further Clinical Review?

Infection Or Deterioration

An assessment needs a clear route for escalating suspected infection or deterioration. A procurement discussion must not delay urgent clinical review.

For diabetes-related foot infections, IWGDF/IDSA recommends urgent surgical consultation for severe infection and certain complicated moderate infections, including deep abscess or severe limb ischaemia. Where infection and peripheral arterial disease coexist, surgical and vascular input may both be required. NPWT is not recommended as a treatment for the infection itself. These are diabetic-foot recommendations. IWGDF/IDSA Infection Guideline, 2023

Bleeding Risk And Exposed Structures

Before NPWT is considered, clinical review must address bleeding risk, medicines affecting clotting, exposed structures and the proposed dressing interface. Suitability depends on the specific system’s current instructions for use (IFU) and the clinical circumstances.

For example, FDA guidance for non-powered NPWT identifies contraindications and precautions involving eschar, untreated osteomyelitis, certain fistulas, malignancy and exposed anatomy. That document covers a defined device category; its list must not be presented as the universal label for every powered or non-powered system. FDA Non-Powered NPWT Guidance

Stable, Dry Heel Eschar

Not every area of eschar automatically requires removal. WHS guidance states that a heel pressure ulcer with stable, intact, dry eschar and no signs of inflammation or infection does not need debridement. Clinical goals and monitoring remain important; new infection signs change the assessment. This specific exception is not permission to leave all necrotic wounds untreated. WHS Guideline 3.9

Does Debridement Automatically Lead To NPWT?

No. The team needs a separate, documented rationale for NPWT after reassessment. Wound category, remaining risks, treatment goals and the applicable IFU all matter.

For diabetes-related foot wounds, IWGDF 2023 conditionally supports considering NPWT alongside standard care for postsurgical wounds, based on low-certainty evidence. It recommends against NPWT as an adjunct for healing non-surgically related diabetes foot ulcers, also based on low-certainty evidence. This distinction must not be generalised to all wounds or obscured by a broad claim that NPWT follows every debridement. IWGDF Wound Healing Recommendations

How Does Assessment Inform Service And Procurement Planning?

Once the clinical pathway is defined, you can turn its requirements into questions for suppliers:

• Which exact system and current IFU are being evaluated?
• Which dressings, tubing and collection components are documented for that system?
• What training, consumable supply and technical support will the service need?
• Who will review progress, respond to device problems and arrange clinical escalation?

Keep these questions separate from clinical eligibility. You can review the ultrasonic wound debridement system range for product discussions, but a catalogue cannot confirm suitability for an individual wound.

Frequently Asked Questions

Who Should Sign Off The Assessment?

The responsible healthcare professional should make and document the clinical decision under local policy. You can check that this responsibility is assigned; a supplier’s quotation or product recommendation is not clinical sign-off.

Can A Photograph Replace The Assessment Record?

No. An image may support documentation, but it cannot establish the complete history, perfusion findings or treatment risks. Use the clinical assessment record when discussing equipment requirements, with patient information handled under institutional privacy rules.

What If Part Of The Wound Cannot Be Assessed?

Record the limitation and the clinician’s plan for resolving it. An unknown depth or unclear structure should remain explicitly unknown; it should not be converted into an assumed device or dressing requirement.

Can The Same Checklist Be Used For Every Wound?

A shared documentation format can support communication, but clinical interpretation must reflect the wound category. A diabetic-foot recommendation or a heel-pressure-injury exception does not automatically apply to another wound population.

What Should Happen When Findings Change?

The service needs a documented reassessment and escalation process. Changes in the wound or the person’s condition can affect the care plan. A previous equipment order is not evidence that the original treatment decision remains appropriate.

Final Thoughts

Use assessment findings to define the care pathway before choosing equipment. For product documents and configuration questions, contact PROMED. Treatment eligibility, timing and reassessment remain the responsibility of the clinical team.

For professional education and service planning; not an individual treatment protocol.